TransEnterix receives FDA 510(k) clearance for Senhance Ultrasonic System
TransEnterix announced the Company received FDA 510(k) clearance for its Senhance™ Ultrasonic System. The Senhance™ System is the first new abdominal robotic surgery platform to receive FDA clearance since 2000. January 15, 2019